Skip to content
healthcare.dev

Top Value Effervescent Pain Relief

NDC 50201-4212, Apirin, Citric Acid, Sodium Bicarbonate, tablet, effervescent, from Tower Laboratories Ltd.

Product NDC
50201-4212
Status
Listed
Labeler
Tower Laboratories Ltd
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50201-4212 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN325 mg/1
  • ANHYDROUS CITRIC ACID1000 mg/1
  • SODIUM BICARBONATE1916 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Alkalinizing Activity [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Cyclooxygenase Inhibitors [MoA]; Decreased Coagulation Factor Activity [PE]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

Package NDCNDC-11Package
50201-4212-05020142120010 POUCH in 1 CARTON (50201-4212-0) / 2 TABLET, EFFERVESCENT in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50201-4212 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50201-4212 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50201-4212. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.